Cleared Traditional

K053345 - PRO-LINE CT POWER INJECTABLE CVC, MODELS CTLINES5S, CTLINE6D

K053345 is an FDA 510(k) clearance for PRO-LINE CT POWER INJECTABLE CVC, manufactured by Medcomp. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K053345 · Medcomp · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
105d
Days
Class 2
Risk

K053345 is an FDA 510(k) clearance for the PRO-LINE CT POWER INJECTABLE CVC, MODELS CTLINES5S, CTLINE6D. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Medcomp (Harleysville, US). The FDA issued a Cleared decision on March 17, 2006 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medcomp devices

FDA 510(k) Submission Details - K053345

510(k) Number K053345 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2005
Decision Date March 17, 2006
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 216
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K053345.
POWERHICKMAN LONG-TERM INTRAVASCULAR CATHETER
K061179 · C.R. Bard, Inc. · Aug 2006
1.9F X 20 CM VASCU-PICC, MODELS VP1.9S20 AND VP1.9S50
K061986 · Medcomp · Aug 2006
ANGIODYNAMIC, INC. MORPHEUS CT PICC AND PROCEDURE KIT
K060887 · AngioDynamics, Inc. · Apr 2006
POWERPICC
K053501 · Bard Access Systems, Inc. · Jan 2006
POWERPICC
K051672 · Bard Access Systems, Inc. · Nov 2005
POWERPICC, POLY PER-Q-CATH, 6 FR TL POLY PER-Q-CATH, POWER HOHN AND POWER LINE
K051991 · C.R. Bard, Inc. · Oct 2005